Literature DB >> 12374825

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.

Lubomir Grozdanov1, Ulrich Zähringer, Gabriele Blum-Oehler, Lore Brade, Anke Henne, Yuriy A Knirel, Ursula Schombel, Jürgen Schulze, Ulrich Sonnenborn, Gerhard Gottschalk, Jörg Hacker, Ernst T Rietschel, Ulrich Dobrindt.   

Abstract

Structural analysis of lipopolysaccharide (LPS) isolated from semirough, serum-sensitive Escherichia coli strain Nissle 1917 (DSM 6601, serotype O6:K5:H1) revealed that this strain's LPS contains a bisphosphorylated hexaacyl lipid A and a tetradecasaccharide consisting of one E. coli O6 antigen repeating unit attached to the R1-type core. Configuration of the GlcNAc glycosidic linkage between O-antigen oligosaccharide and core (beta) differs from that interlinking the repeating units in the E. coli O6 antigen polysaccharide (alpha). The wa(*) and wb(*) gene clusters of strain Nissle 1917, required for LPS core and O6 repeating unit biosyntheses, were subcloned and sequenced. The DNA sequence of the wa(*) determinant (11.8 kb) shows 97% identity to other R1 core type-specific wa(*) gene clusters. The DNA sequence of the wb(*) gene cluster (11 kb) exhibits no homology to known DNA sequences except manC and manB. Comparison of the genetic structures of the wb(*)(O6) (wb(*) from serotype O6) determinants of strain Nissle 1917 and of smooth and serum-resistant uropathogenic E. coli O6 strain 536 demonstrated that the putative open reading frame encoding the O-antigen polymerase Wzy of strain Nissle 1917 was truncated due to a point mutation. Complementation with a functional wzy copy of E. coli strain 536 confirmed that the semirough phenotype of strain Nissle 1917 is due to the nonfunctional wzy gene. Expression of a functional wzy gene in E. coli strain Nissle 1917 increased its ability to withstand antibacterial defense mechanisms of blood serum. These results underline the importance of LPS for serum resistance or sensitivity of E. coli.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374825      PMCID: PMC135379          DOI: 10.1128/JB.184.21.5912-5925.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

1.  Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter.

Authors:  E V Vinogradov; R Pantophlet; L Dijkshoorn; L Brade; O Holst; H Brade
Journal:  Eur J Biochem       Date:  1996-08-01

2.  Efficient random subcloning of DNA sheared in a recirculating point-sink flow system.

Authors:  P J Oefner; S P Hunicke-Smith; L Chiang; F Dietrich; J Mulligan; R W Davis
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette.

Authors:  S Lukomski; R A Hull; S I Hull
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

Review 5.  Role of O-antigen variation in the immune response.

Authors:  P Reeves
Journal:  Trends Microbiol       Date:  1995-10       Impact factor: 17.079

Review 6.  Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides.

Authors:  U Zähringer; B Lindner; E T Rietschel
Journal:  Adv Carbohydr Chem Biochem       Date:  1994       Impact factor: 12.200

7.  Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

Authors:  H A Malchow
Journal:  J Clin Gastroenterol       Date:  1997-12       Impact factor: 3.062

8.  Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Authors:  W Kruis; E Schütz; P Fric; B Fixa; G Judmaier; M Stolte
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

9.  Properties of Escherichia coli strains of serotype O6.

Authors:  G Blum; R Marre; J Hacker
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

10.  Structural comparison of the O6 specific polysaccharides from E. coli O6:K2:H1, E. coli O6:K13:H1, and E. coli O6:K54:H10.

Authors:  B Jann; A A Shashkov; H Kochanowski; K Jann
Journal:  Carbohydr Res       Date:  1994-10-17       Impact factor: 2.104

View more
  63 in total

1.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

2.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Authors:  A Grabig; D Paclik; C Guzy; A Dankof; D C Baumgart; J Erckenbrecht; B Raupach; U Sonnenborn; J Eckert; R R Schumann; B Wiedenmann; A U Dignass; A Sturm
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Authors:  Franco Scaldaferri; Viviana Gerardi; Francesca Mangiola; Loris Riccardo Lopetuso; Marco Pizzoferrato; Valentina Petito; Alfredo Papa; Jovana Stojanovic; Andrea Poscia; Giovanni Cammarota; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

4.  The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Genes Nutr       Date:  2011-04-16       Impact factor: 5.523

5.  Bacteria as tumor therapeutics?

Authors:  Tobias A Oelschlaeger
Journal:  Bioeng Bugs       Date:  2010-01-15

6.  Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.

Authors:  Alla Splichalova; Igor Splichal; Petra Chmelarova; Ilja Trebichavsky
Journal:  J Clin Immunol       Date:  2011-01-12       Impact factor: 8.317

7.  Molecular dynamics and NMR spectroscopy studies of E. coli lipopolysaccharide structure and dynamics.

Authors:  Emilia L Wu; Olof Engström; Sunhwan Jo; Danielle Stuhlsatz; Min Sun Yeom; Jeffery B Klauda; Göran Widmalm; Wonpil Im
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

8.  NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors:  Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.